These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30059069)

  • 41. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
    Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
    Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas].
    Yamada SM; Bruner JM; Berger MS; Morrison RS
    No To Shinkei; 1996 Apr; 48(4):363-70. PubMed ID: 8679334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression.
    Comincini S; Facoetti A; Del Vecchio I; Peoc'h K; Laplanche JL; Magrassi L; Ceroni M; Ferretti L; Nano R
    Anticancer Res; 2004; 24(3a):1507-17. PubMed ID: 15274317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma.
    Kuroda J; Nobusawa S; Nakamura H; Yokoo H; Ueda R; Makino K; Yano S; Kuratsu J
    Neuropathology; 2016 Apr; 36(2):181-6. PubMed ID: 26375727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV.
    Narsia N; Ramagiri P; Ehrmann J; Kolar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesenchymal/radioresistant traits in granular astrocytomas: evidence from a combined clinical and molecular approach.
    Senetta R; Mellai M; Manini C; Castellano I; Bertero L; Pittaro A; Schiffer D; Boldorini R; Cassoni P
    Histopathology; 2016 Aug; 69(2):329-37. PubMed ID: 26845757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance.
    Thota B; Shukla SK; Srividya MR; Shwetha SD; Arivazhagan A; Thennarasu K; Chickabasaviah YT; Hegde AS; Chandramouli BA; Somasundaram K; Santosh V
    Am J Clin Pathol; 2012 Aug; 138(2):177-84. PubMed ID: 22904127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical analysis of GFAP-δ and nestin in cerebral astrocytomas.
    Brehar FM; Arsene D; Brinduse LA; Gorgan MR
    Brain Tumor Pathol; 2015 Apr; 32(2):90-8. PubMed ID: 25178519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of novel genomic aberrations in anaplastic astrocytomas by GTG-banding, SKY, locus-specific FISH, and high density SNP-array.
    Holland H; Ahnert P; Koschny R; Kirsten H; Bauer M; Schober R; Meixensberger J; Fritzsch D; Krupp W
    Pathol Res Pract; 2012 Jun; 208(6):325-30. PubMed ID: 22575435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of survivin and DNA topoisomerase IIα in diffuse and anaplastic astrocytomas.
    Varughese RK; Skjulsvik AJ; Torp SH
    Pathol Res Pract; 2017 Apr; 213(4):339-347. PubMed ID: 28214203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The significance of gemistocytes in astrocytoma.
    Yang HJ; Kim JE; Paek SH; Chi JG; Jung HW; Kim DG
    Acta Neurochir (Wien); 2003 Dec; 145(12):1097-103; discussion 1103. PubMed ID: 14663567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis.
    Korkolopoulou P; Patsouris E; Konstantinidou AE; Pavlopoulos PM; Kavantzas N; Boviatsis E; Thymara I; Perdiki M; Thomas-Tsagli E; Angelidakis D; Rologis D; Sakkas D
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):267-78. PubMed ID: 15175080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
    Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
    Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malignant transformation of a pleomorphic xanthoastrocytoma.
    Dickerman RD
    Acta Neurochir (Wien); 2006 Jan; 148(1):98. PubMed ID: 16369863
    [No Abstract]   [Full Text] [Related]  

  • 58. Nucleolar organizer regions (AgNORs) in astrocytic tumors.
    Pedal WP; Warzok RW; Hufnagl P; Roth K
    Zentralbl Pathol; 1994 Mar; 140(1):89-94. PubMed ID: 7515679
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Classification of astrocytomas and malignant astrocytomas by principal components analysis and a neural net.
    McKeown MJ; Ramsay DA
    J Neuropathol Exp Neurol; 1996 Dec; 55(12):1238-45. PubMed ID: 8957447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts.
    Jones DT; Mulholland SA; Pearson DM; Malley DS; Openshaw SW; Lambert SR; Liu L; Bäcklund LM; Ichimura K; Collins VP
    Acta Neuropathol; 2011 Jun; 121(6):753-61. PubMed ID: 21327941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.